Pituitary adenylate cyclase-activating polypeptide stimulates cardiodilatin/atrial natriuretic peptide (CDD/ANP-(99-126) secretion from cultured neonatal rat myocardiocytes - PubMed (original) (raw)
Comparative Study
. 1995 Nov 30;291(3):335-42.
doi: 10.1016/0922-4106(95)90074-8.
Affiliations
- PMID: 8719418
- DOI: 10.1016/0922-4106(95)90074-8
Comparative Study
Pituitary adenylate cyclase-activating polypeptide stimulates cardiodilatin/atrial natriuretic peptide (CDD/ANP-(99-126) secretion from cultured neonatal rat myocardiocytes
I Bäsler et al. Eur J Pharmacol. 1995.
Abstract
It has been reported that the highly homologous neuropeptides pituitary adenylate cyclase-activating peptide (PACAP) and vasoactive intestinal polypeptide (VIP) exert similar cardiovascular effects in vivo. In the present study we compared the effects of these neuropeptides on myocardial cyclic AMP content and the release of immunoreactive CDD/ANP-(99-126) (atrial natriuretic peptide). In cultured neonatal rat cardiomyocytes PACAP and VIP evoke concentration-dependent increases in intracellular cyclic AMP content but responses to VIP are markedly less. PACAP stimulates the release of CDD/ ANP-(99-126) in a concentration-dependent manner with a threshold concentration of 1 nM, and up to a 6-fold increase in basal secretion at 1 microM PACAP. In contrast. VIP had no effect on the release of CDD/ANP. Pretreatment of cells with the competitive PACAP-antagonist, PACAP-6-38 (1 microM), significantly reduces the effects of PACAP on intracellular cyclic AMP and on CDD/ANP-(99-126) secretion and abolishes the effects of VIP on cyclic AMP. Pretreatment with VIP-receptor antagonist (1 microM) prevents the cyclic AMP-response to VIP while increases in cyclic AMP as well as stimulation of CDD/ANP-(99-126) release by PACAP are not affected. It is concluded that both neuropeptides directly influence cardiac myocytes through an increase in intracellular cyclic AMP. Release of CDD/ ANP-(99-126) by PACAP may be involved in the decrease in blood pressure that follows intravenous administration of this peptide. The higher potency of PACAP to induce cyclic AMP synthesis, its stimulating effect on the release of CDD/ANP-(99-126) and the finding that the VIP-receptor antagonist inhibits responses to VIP but not to PACAP suggest that PACAP activates cardiac myocytes through a PACAP-specific receptor.
Similar articles
- The effect of pituitary adenylate cyclase activating polypeptide on cultured rat cardiocytes as a cardioprotective factor.
Sano H, Miyata A, Horio T, Nishikimi T, Matsuo H, Kangawa K. Sano H, et al. Regul Pept. 2002 Nov 15;109(1-3):107-13. doi: 10.1016/s0167-0115(02)00193-3. Regul Pept. 2002. PMID: 12409222 - VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L, Ahrén B, Edgren G, Degerman E. Akesson L, et al. Endocrinology. 2005 Feb;146(2):744-50. doi: 10.1210/en.2004-0504. Epub 2004 Oct 28. Endocrinology. 2005. PMID: 15514088 - Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
Rawlings SR, Piuz I, Schlegel W, Bockaert J, Journot L. Rawlings SR, et al. Endocrinology. 1995 May;136(5):2088-98. doi: 10.1210/endo.136.5.7720658. Endocrinology. 1995. PMID: 7720658 - Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis.
Nussdorfer GG, Malendowicz LK. Nussdorfer GG, et al. Peptides. 1998;19(8):1443-67. doi: 10.1016/s0196-9781(98)00102-8. Peptides. 1998. PMID: 9809661 Review. - Interactions of VIP, secretin and PACAP(1-38) with phospholipids: a biological paradox revisited.
Krishnadas A, Onyüksel H, Rubinstein I. Krishnadas A, et al. Curr Pharm Des. 2003;9(12):1005-12. doi: 10.2174/1381612033455206. Curr Pharm Des. 2003. PMID: 12678867 Review.
Cited by
- Pituitary adenylate cyclase-activating polypeptide expression and modulation of neuronal excitability in guinea pig cardiac ganglia.
Braas KM, May V, Harakall SA, Hardwick JC, Parsons RL. Braas KM, et al. J Neurosci. 1998 Dec 1;18(23):9766-79. doi: 10.1523/JNEUROSCI.18-23-09766.1998. J Neurosci. 1998. PMID: 9822736 Free PMC article.